Skip to content

News Events Jobs For Employers Sponsorship

Log In Sign Up

News & Articles

The latest in life sciences from across BioBuzz’s regional hubs.

Career & Professional Development 430 Events 211 Funding 368 Industry Trends 1567 Manufacturing 192 People 1009 Policy 120 Real Estate 228 Research 570 Workforce 242

5 Questions With 231 Ambassadors of Buzz 27 Annual Awards 14 Career Tips 13 Chronicles in Leadership 1 Editorial 327 Featured Employer 12 In Conversation 129 People on the Move 168 Press Release 1074 Quick Hits 161 Sponsored Content 130 Talent Lab 36 The XYZ 1 What's The Buzz!? 20

From To

0 filters

Showing 0 of 0 results

Rockville’s Ascentage Pharma Receives Breakthrough Therapy Designation in China for Lisaftoclax in First-Line CLL/SLL

BioHealth Capital Region Manufacturing Research

Rockville’s Ascentage Pharma Receives Breakthrough Therapy Designation in China for Lisaftoclax in First-Line CLL/SLL

October 23, 2026

BioHealth Capital Region

FDA Launches Neuroscience Innovation Program With Initial Focus on Alzheimer’s Prevention

BioHealth Capital Region Industry Trends

FDA Launches Neuroscience Innovation Program With Initial Focus on Alzheimer’s Prevention

October 23, 2026

BioHealth Capital Region

Brii Biosciences Launches BRiSC™, a Dual-Targeting siRNA Discovery Platform

North Carolina Industry Trends Research

Brii Biosciences Launches BRiSC™, a Dual-Targeting siRNA Discovery Platform

October 23, 2026

North Carolina

People on the Move: Stephen Brannan and John Young Join Slate Medicines as Board Members

North Carolina Career & Professional Development People

People on the Move: Stephen Brannan and John Young Join Slate Medicines as Board Members

October 23, 2026

North Carolina

People on the Move: Roger Lias Named Head of Commercial at Bora Biologics

BioHealth Capital Region Career & Professional Development People

People on the Move: Roger Lias Named Head of Commercial at Bora Biologics

October 22, 2026

BioHealth Capital Region

People on the Move: David Rubenstein Named Chief Scientist at Adial Pharmaceuticals

BioHealth Capital Region Career & Professional Development People

People on the Move: David Rubenstein Named Chief Scientist at Adial Pharmaceuticals

October 22, 2026

BioHealth Capital Region

Rockville’s MacroGenics Doses First Patient in Phase 1 Study of MGC030, Its Third Clinical-Stage ADC

BioHealth Capital Region Manufacturing Research

Rockville’s MacroGenics Doses First Patient in Phase 1 Study of MGC030, Its Third Clinical-Stage ADC

October 22, 2026

BioHealth Capital Region

Gaithersburg’s Georgiamune Signs Potential $1.1 Billion Global Cancer Drug Licensing Deal With Menarini

BioHealth Capital Region Industry Trends

Gaithersburg’s Georgiamune Signs Potential $1.1 Billion Global Cancer Drug Licensing Deal With Menarini

October 22, 2026

BioHealth Capital Region

People on the Move: Matthew Klein Joins CREO as Chief Executive Officer

North Carolina Career & Professional Development People

People on the Move: Matthew Klein Joins CREO as Chief Executive Officer

October 22, 2026

North Carolina

Fortrea Closes $45 Million Deal for Worldwide Clinical Trials’ Early Phase Division

North Carolina Funding Industry Trends

Fortrea Closes $45 Million Deal for Worldwide Clinical Trials’ Early Phase Division

October 22, 2026

North Carolina

Johns Hopkins Leads Up to $52.1 Million Federal Research Effort to Advance AI-Driven Protein Research

BioHealth Capital Region Funding

Johns Hopkins Leads Up to $52.1 Million Federal Research Effort to Advance AI-Driven Protein Research

October 22, 2026

BioHealth Capital Region

Maryland’s OS Therapies Raises $7.2 Million to Advance Osteosarcoma Immunotherapy Toward Regulatory Review

BioHealth Capital Region Funding

Maryland’s OS Therapies Raises $7.2 Million to Advance Osteosarcoma Immunotherapy Toward Regulatory Review

October 22, 2026

BioHealth Capital Region

Emergent BioSolutions CFO Richard Lindahl to Retire

BioHealth Capital Region Career & Professional Development People

Emergent BioSolutions CFO Richard Lindahl to Retire

October 22, 2026

BioHealth Capital Region

Buzzin’ Brood Student Spotlight: Sedigheh Bagheriziari, Montgomery College

BioHealth Capital Region Career & Professional Development People

Buzzin’ Brood Student Spotlight: Sedigheh Bagheriziari, Montgomery College

October 22, 2026

BioHealth Capital Region

People on the Move: Dr. Patricia Beaston Named Chief Medical Officer of Seraxis and Future BetaNova Biotherapeutics

BioHealth Capital Region People Workforce

People on the Move: Dr. Patricia Beaston Named Chief Medical Officer of Seraxis and Future BetaNova Biotherapeutics

October 22, 2026

BioHealth Capital Region

Vogenx Launches Phase 2b EMERGE Trial of Oral Mizagliflozin for Post-Bariatric Hypoglycemia

North Carolina Research Press Release

Vogenx Launches Phase 2b EMERGE Trial of Oral Mizagliflozin for Post-Bariatric Hypoglycemia

October 22, 2026

North Carolina

People on the Move: Travis Psencik Joins FUJIFILM as Program Manager

North Carolina Career & Professional Development People

People on the Move: Travis Psencik Joins FUJIFILM as Program Manager

October 22, 2026

North Carolina

Greater Philadelphia Life Sciences News: CHOP Spinout Arctic Therapeutics Closes $21.5M, Merck’s New West Point Lab & More

Greater Philadelphia Career & Professional Development Events

Greater Philadelphia Life Sciences News: CHOP Spinout Arctic Therapeutics Closes $21.5M, Merck’s New West Point Lab & More

October 22, 2026

Greater Philadelphia

Plymouth Meeting’s INOVIO Wins $80.4 Million Judgment Against VGXI and GeneOne Life Science

Greater Philadelphia Funding

Plymouth Meeting’s INOVIO Wins $80.4 Million Judgment Against VGXI and GeneOne Life Science

October 22, 2026

Greater Philadelphia

Immunocore Doses First Patient in Phase 1 Trial of IMC-S118AI, Its First Tissue-Specific Autoimmune Candidate, for Type 1 Diabetes

Greater Philadelphia Industry Trends Research

Immunocore Doses First Patient in Phase 1 Trial of IMC-S118AI, Its First Tissue-Specific Autoimmune Candidate, for Type 1 Diabetes

October 22, 2026

Greater Philadelphia

Malvern’s Ocugen Licenses OCU400 Gene Therapy to Roots Pharmaceutical for the Middle East and North Africa

Greater Philadelphia Industry Trends Research

Malvern’s Ocugen Licenses OCU400 Gene Therapy to Roots Pharmaceutical for the Middle East and North Africa

October 22, 2026

Greater Philadelphia

Stay in the Loop

Get the latest life science news, events, and opportunities delivered to your inbox every week.

Email address

Website

You’ll get news for your region. Change topics or unsubscribe from any email.

Explore

News
Events
Resources & Tools
Membership
Solutions
BioCatalyst

Company

About Us
Team
History
Contact

© 2026 BioBuzz Networks. All rights reserved.

Privacy Policy · Terms of Service ·

Share your feedback

Help us improve your BioBuzz experience.

We use cookies to give you the best experience on our website. Choose which categories you want to allow.

Cookie Preferences

Choose which categories you want to allow. Strictly necessary cookies are always active.

Strictly Necessary Required for the website to function. Cannot be disabled.

Analytics Help us understand how visitors use the site.

Marketing Used to deliver relevant ads and track campaigns.

Other Additional third-party services and integrations.